Role of CD8+ and CD4+ T cells in the rejection of murine intestinal allografts.
He
G
G
Department of Surgery, University of Chicago, Pritzker School of Medicine, Illinois, USA.
Hart
J
J
Thistlethwaite
J R
JR
Newell
K A
KA
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D005805:Genes, MHC Class I; D005802:Genes, MHC Class II; D006084:Graft Rejection / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D007165:Immunosuppression Therapy / Q000379:methods; D007421:Intestine, Small / Q000637:transplantation*; D008212:Lymphocyte Depletion; D051379:Mice; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D018345:Mice, Knockout; D014184:Transplantation, Homologous / Q000276:immunology*; D014185:Transplantation, Isogeneic / Q000276:immunology*
D000911:Antibodies, Monoclonal; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II